Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

3 Mar 2020 11:00

RNS Number : 8476E
NMC Health Plc
03 March 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

NMC HEALTH PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Morgan Stanley

City and country of registered office (if applicable)

Wilmington, Delaware, USA

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

27/02/2020

6. Date on which issuer notified (DD/MM/YYYY):

02/03/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

1.05%

3.99%

5.04%

208,703,861

Position of previous notification (if

applicable)

Below 3%

Below 3%

Below 3%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B7FC0762

2,197,197

1.05%

SUBTOTAL 8. A

2,197,197

1.05%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Fixed Term Contractual pre-emption right (Ordinary Shares)

30/04/2020

at any time

1,000,000

0.48%

Right of recall over securities lending agreements

at any time

at any time

489,026

0.23%

SUBTOTAL 8. B 1

1,489,026

0.71%

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

Equity Swap

07/05/2020

at any time

Cash

4,805

0.002%

Equity Swap

09/09/2020

at any time

Cash

4,000,000

1.92%

Equity Swap

18/01/2021

at any time

Cash

16,075

0.01%

Equity Swap

27/01/2021

at any time

Cash

10,000

0.005%

Equity Swap

05/03/2021

at any time

Cash

1,542

0.001%

Equity Swap

18/10/2021

at any time

Cash

2,000,000

0.96%

Equity Swap

22/11/2021

at any time

Cash

86,695

0.04%

Equity Swap

29/11/2021

at any time

Cash

250,000

0.12%

Equity Swap

09/12/2021

at any time

Cash

2,444

0.001%

Equity Swap

23/12/2021

at any time

Cash

303,791

0.15%

Equity Swap

10/01/2022

at any time

Cash

12,901

0.01%

Equity Swap

18/07/2022

at any time

Cash

150,146

0.07%

SUBTOTAL 8.B.2

6,838,399

3.28%

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Morgan Stanley

Morgan Stanley Capital Management, LLC

Morgan Stanley Domestic Holdings, Inc.

Morgan Stanley Capital Services LLC

Morgan Stanley

Morgan Stanley Capital Management, LLC

Morgan Stanley Domestic Holdings, Inc.

Morgan Stanley & Co. LLC

Morgan Stanley

Morgan Stanley International Holdings Inc.

Morgan Stanley International Limited

Morgan Stanley Investments (UK)

Morgan Stanley & Co. International plc

3.53%

4.59%

Morgan Stanley

Morgan Stanley International Holdings Inc.

Morgan Stanley International Limited

Morgan Stanley Europe Holding SE

Morgan Stanley Europe SE

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Of the total voting rights attached to shares in Section 8A, 996,664 (0.48%) of these are the result of stock borrowing agreements.

 

Place of completion

Glasgow

Date of completion

02/03/2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLSSMFSDESSEFD
Date   Source Headline
13th Oct 201510:23 amBUSForm 8.3 - NMC Health Plc Amendment
13th Oct 20159:39 amBUSForm 8.3 - NMC Health Plc
12th Oct 20153:21 pmBUSForm 8.3 - NMC HEALTH PLC
12th Oct 20153:10 pmRNSForm 8.3 - NMC Health Plc
12th Oct 20153:06 pmRNSForm 8.3 - NMC Health Plc
12th Oct 20153:04 pmRNSForm 8.3 - Al Noor Hospitals Group Plc
12th Oct 20152:33 pmRNSForm 8.3 - NMC HEALTH GROUP PLC
12th Oct 20151:42 pmRNSBoard Change
12th Oct 201511:35 amRNSForm 8.5 (EPT/RI)
12th Oct 201510:37 amRNSForm 8.5 (EPT/RI)-NMC Health Plc
12th Oct 20157:00 amRNSRule 2.10 Announcement
9th Oct 20153:00 pmRNSNMC Health confirms a possible offer for Al Noor
9th Oct 20152:18 pmRNSStatement re Possible Offer
28th Sep 20157:00 amRNSDirector/PDMR Shareholding
9th Sep 20151:53 pmRNSDirector/PDMR Shareholding
26th Aug 20157:00 amRNSHalf Yearly Report
25th Aug 201510:48 amRNSClosing of ProVita acquisition
24th Aug 20153:41 pmRNSNMC Opens New Super Speciality Hospital in UAE
17th Aug 20151:22 pmRNSClosing Dr Sunny Healthcare Group acquisition
10th Aug 201510:28 amRNSNotification of Half Year Results
18th Jun 20154:35 pmRNSPrice Monitoring Extension
16th Jun 20155:04 pmRNSResults of voting at Annual General Meeting
15th Jun 20157:00 amRNSAcquisition of ProVita
4th Jun 20157:05 amRNSClosing of Americare Group acquisition
4th Jun 20157:00 amRNSAppointment of J.P.Morgan Cazenove
20th May 201511:30 amRNSDirector/PDMR Shareholding
20th May 20159:00 amRNSAGM and Dividend Timetable
29th Apr 20157:00 amRNSAcquisition
7th Apr 20151:39 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1) (a)
30th Mar 20157:00 amRNSAppointment of FTI Consulting
30th Mar 20157:00 amRNSAppointment of HSBC as Joint Corporate Broker
26th Feb 20151:58 pmRNSDirector/PDMR Shareholding
26th Feb 201511:48 amRNSOptions grant award announcement
24th Feb 20157:02 amRNSAcquisition of Clinica Eugin
24th Feb 20157:00 amRNSFY 14 Results
16th Feb 20157:00 amRNSNew Financing Facility & Update to Group Strategy
30th Oct 20141:36 pmRNSNOTIFICATION MADE IN ACCORDANCE WITH RULE 3.1.4
28th Oct 20147:00 amRNSInterim Management Statement and Management Change
19th Aug 20147:00 amRNSHALF-YEARLY FINANCIAL REPORT
30th Jun 20141:00 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1)(a)
26th Jun 20144:09 pmRNSBoard Change
26th Jun 20144:07 pmRNSResults of voting at Annual General Meeting
26th Jun 201412:58 pmRNS2014 Half-Year pre-close statement
3rd Jun 20149:53 amRNSAGM and Proposed Board Changes
29th Apr 20147:00 amRNSInterim Management Statement
4th Apr 20144:12 pmRNSNOTIFICATION IN ACCORDANCE WITH RULE 3.1.4 (1) (a)
26th Mar 201410:16 amRNSBoard Change
25th Feb 20141:16 pmRNSDividend Timetable and AGM notice
25th Feb 20147:02 amRNSDirectorate Change
25th Feb 20147:00 amRNSFull Year Results ending 2013

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.